Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Hyperion Therapeutics to Present at Needham's 12th Annual Healthcare Conference



Hyperion Therapeutics to Present at Needham's 12th Annual Healthcare
Conference

SOUTH SAN FRANCISCO, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- Hyperion
Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to
present at Needham's 12^th Annual Healthcare Conference on Tuesday, April 30
at 9:20 a.m. ET.

Donald J. Santel, Chief Executive Officer of Hyperion, will provide a company
overview. To access the live webcast and subsequent archived recording, please
visit Hyperion's website at http://investors.hyperiontx.com/events.cfm.

About Hyperion Therapeutics

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company
committed to developing and delivering life-changing treatments for orphan
diseases and hepatology.

CONTACT: Shari Annes, Investor Relations
         (650) 888-0902
         sannes@annesassociates.com
        
         Kristie Kuhl, Media Relations
         (203) 556-7417
         kkuhl@makovsky.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement